Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Lung Neoplasms and CYP4F2[original query] |
---|
Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients. Frontiers in pharmacology 2018 9 360. Wang Cong, Chen Fang, Liu Yichen, Xu Qingqing, Guo Liang, Zhang Xiaoqing, Ruan Yunfeng, Shi Ye, Shen Lu, Li Mo, Du Huihui, Sun Xiaofang, Ma Jingsong, He Lin, Qin Shengyi |
CYP4F2 and CYP3A5 gene polymorphisms and lung cancer in Chinese Han population. Clinical and experimental medicine 2020 Apr . He Ruiqing, Li Meng, Li Anqi, Dang Wenhui, Yang Tian, Li Jing, Zhang Ning, Jin Tianbo, Chen Mingw |
Pharmacogenetics of the cytochromes P450: Selected pharmacological and toxicological aspects. Advances in pharmacology (San Diego, Calif.) 2022 8 95 49-72. Daly Ann |
Genetic polymorphisms in CYP4F2 may be associated with lung cancer risk among females and no-smoking Chinese population. Frontiers in oncology 2023 3 13 1114218. Shi Hongyang, Zhang Yonghong, Wang Yu, Fang Ping, Liu Y |
- Page last reviewed:Feb 1, 2024
- Content source: